211 related articles for article (PubMed ID: 27183723)
1. [THE LONG NON-CODING RNA ASSOCIATED WITH CANCEROGENESIS: BIOLOGICAL SIGNIFICANCE AND PERSPECTIVES OF APPLICATION IN DIAGNOSTIC].
Kit OI; Kirichenko EY; Kirichenko YG; Novikova IA; Selyutina ON; Filippova SY
Klin Lab Diagn; 2016 Jan; 61(1):13-6. PubMed ID: 27183723
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNAs regulate drug resistance in cancer.
Liu K; Gao L; Ma X; Huang JJ; Chen J; Zeng L; Ashby CR; Zou C; Chen ZS
Mol Cancer; 2020 Mar; 19(1):54. PubMed ID: 32164712
[TBL] [Abstract][Full Text] [Related]
3. BCYRN1: An oncogenic lncRNA in diverse cancers.
Ghafouri-Fard S; Dashti S; Hussen BM; Farsi M; Taheri M
Pathol Res Pract; 2021 Apr; 220():153385. PubMed ID: 33647864
[TBL] [Abstract][Full Text] [Related]
4. Review: Regulation of the cancer epigenome by long non-coding RNAs.
Forrest ME; Khalil AM
Cancer Lett; 2017 Oct; 407():106-112. PubMed ID: 28400335
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA HOTAIR: A novel oncogene (Review).
Yu X; Li Z
Mol Med Rep; 2015 Oct; 12(4):5611-8. PubMed ID: 26238267
[TBL] [Abstract][Full Text] [Related]
6. Emerging roles of long non-coding RNAs in cancer.
Chatterjee M; Sengupta S
J Biosci; 2019 Mar; 44(1):. PubMed ID: 30837373
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the long noncoding RNA NEAT1 in carcinogenesis.
Klec C; Prinz F; Pichler M
Mol Oncol; 2019 Jan; 13(1):46-60. PubMed ID: 30430751
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.
Niu ZS; Niu XJ; Wang WH
World J Gastroenterol; 2017 Aug; 23(32):5860-5874. PubMed ID: 28932078
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNAs in cancer drug resistance development.
Majidinia M; Yousefi B
DNA Repair (Amst); 2016 Sep; 45():25-33. PubMed ID: 27427176
[TBL] [Abstract][Full Text] [Related]
10. Expression and role of long non-coding RNA H19 in carcinogenesis.
Yoshimura H; Matsuda Y; Yamamoto M; Kamiya S; Ishiwata T
Front Biosci (Landmark Ed); 2018 Jan; 23(4):614-625. PubMed ID: 28930564
[TBL] [Abstract][Full Text] [Related]
11. The biological characteristics of transcription factors AP-2α and AP-2γ and their importance in various types of cancers.
Kołat D; Kałuzińska Ż; Bednarek AK; Płuciennik E
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30824562
[TBL] [Abstract][Full Text] [Related]
12. LncRNAs and neoplasia.
Isin M; Dalay N
Clin Chim Acta; 2015 Apr; 444():280-8. PubMed ID: 25748036
[TBL] [Abstract][Full Text] [Related]
13. PCAT-1: A pivotal oncogenic long non-coding RNA in human cancers.
Yang Z; Zhao S; Zhou X; Zhao H; Jiang X
Biomed Pharmacother; 2019 Feb; 110():493-499. PubMed ID: 30530229
[TBL] [Abstract][Full Text] [Related]
14. Novel perspectives of long non-coding RNAs in esophageal carcinoma.
Lin CY; Xu HM
Carcinogenesis; 2015 Nov; 36(11):1255-62. PubMed ID: 26392258
[TBL] [Abstract][Full Text] [Related]
15. TUG1: a pivotal oncogenic long non-coding RNA of human cancers.
Li Z; Shen J; Chan MT; Wu WK
Cell Prolif; 2016 Aug; 49(4):471-5. PubMed ID: 27339553
[TBL] [Abstract][Full Text] [Related]
16. An updated review of the H19 lncRNA in human cancer: molecular mechanism and diagnostic and therapeutic importance.
Alipoor B; Parvar SN; Sabati Z; Ghaedi H; Ghasemi H
Mol Biol Rep; 2020 Aug; 47(8):6357-6374. PubMed ID: 32743775
[TBL] [Abstract][Full Text] [Related]
17. FAL1: A critical oncogenic long non-coding RNA in human cancers.
Lv X; Li Y; Li Y; Li H; Zhou L; Wang B; Zhi Z; Tang W
Life Sci; 2019 Nov; 236():116918. PubMed ID: 31610208
[TBL] [Abstract][Full Text] [Related]
18. Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis.
El Khodiry A; Afify M; El Tayebi HM
World J Gastroenterol; 2018 Feb; 24(5):549-572. PubMed ID: 29434445
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNAs: emerging regulators of tumor angiogenesis.
Sheng SR; Wu JS; Tang YL; Liang XH
Future Oncol; 2017 Jul; 13(17):1551-1562. PubMed ID: 28513194
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
